CHEPLAPHARM Group

CHEPLAPHARM is a leading global specialty pharmaceutical company headquartered in Greifswald, Germany, that focuses on the acquisition and lifecycle management of established legacy brands from major research-based pharmaceutical companies. The company operates a unique business model centered on preserving the availability of trusted medicines that have lost patent protection or are no longer strategic priorities for their original developers. By managing a diverse portfolio across therapeutic areas such as cardiology, oncology, and the central nervous system, CHEPLAPHARM ensures patient access to essential therapies in over 145 countries. Their portfolio includes well-known brands like Valium, Dilatrend, and Xenical, acquired through long-standing partnerships with industry giants like Roche and AstraZeneca. CHEPLAPHARM leverages a lean organizational structure and an extensive network of contract manufacturing and logistics partners to maintain a stable global supply chain.